Taken together, increased ANRIL in ischemic stroke promotes angiogenesis through VEGF/FLT-1 pathway and regulates inflammation by both promotion and inhibition of the NF-κB pathway. Here, CDKN2B-AS1 is linked to ischemic stroke.